{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Henry+Smith&answeringDeptId=201&min-date=2019-06-03&answer.answeringMember.label=Biography+information+for+Amanda+Solloway", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Henry+Smith&answeringDeptId=201&min-date=2019-06-03&answer.answeringMember.label=Biography+information+for+Amanda+Solloway", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Henry+Smith&answeringDeptId=201&min-date=2019-06-03&_metadata=all&answer.answeringMember.label=Biography+information+for+Amanda+Solloway", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Henry+Smith&_page=0&answeringDeptId=201&min-date=2019-06-03&answer.answeringMember.label=Biography+information+for+Amanda+Solloway", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Henry+Smith&answeringDeptId=201&min-date=2019-06-03&answer.answeringMember.label=Biography+information+for+Amanda+Solloway", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Henry+Smith&answeringDeptId=201&min-date=2019-06-03&answer.answeringMember.label=Biography+information+for+Amanda+Solloway", "items" : [{"_about" : "http://data.parliament.uk/resources/1285630", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1285630/answer", "answerText" : {"_value" : "

UKRI is currently funding one study of direct relevance to these areas. UKRI has allocated an initial £1.8 million to the OCTAVE study, led by Professor Iain McInnes, University of Glasgow, for a twelve-month period, and is considering a case for additional funding beyond this. OCTAVE is supporting research on vaccine responses in groups of immune-supressed individuals, including those with inflammatory disorders, high risk cancer patient groups, and patients with severe kidney and liver disease. Cancer patient groups include chronic lymphocytic leukaemia, myeloma, acute leukaemia, and bone marrow transplants. As the OCTAVE study is being managed as a single project it is not possible to give costs for the individual groups.<\/p>

<\/p>

In addition, there are proposals on vaccine responses in high-risk clinical groups under consideration as part of the UKRI COVID-19 Agile call, with announcements to be made shortly. Furthermore, UKRI continues to accept applications for COVID-19 related research, including on this topic, through its active calls, which can be found on the UKRI website.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4372", "label" : {"_value" : "Biography information for Amanda Solloway"} } , "answeringMemberConstituency" : {"_value" : "Derby North"} , "answeringMemberPrinted" : {"_value" : "Amanda Solloway"} , "dateOfAnswer" : {"_value" : "2021-02-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-26T12:13:53.793Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-02-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what plans his Department has to (a) conduct and (b) provide funding for external organisations to conduct research into the effectiveness of covid-19 vaccinations for (a) people with blood cancer and (b) other immunocompromised people.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "152472"} , {"_about" : "http://data.parliament.uk/resources/1180967", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1180967/answer", "answerText" : {"_value" : "

We work with the Department of Health and Social Care (DHSC), Department for International Development, and UK Research and Innovation (UKRI) to support research on platform vaccine technologies and diagnostic tools that can be utilised as a rapid response during a pandemic. These form a component of the current DHSC and UKRI COVID-19 rapid-response call for proposals to address the threat of this novel coronavirus. Platform vaccines and diagnostics are an integral part of UKRI\u2019s current approach for the development and translation of research findings into tangible benefits, with research funded across UKRI councils<\/p>

<\/p>

DHSC and UKRI lead the UK Vaccine Network which brings together funders, industry and academia to identify and target investment opportunities for the most promising vaccines and vaccine technologies, including platform vaccine and diagnostic tools to combat infectious diseases with epidemic potential and to address structural issues related to the UK\u2019s vaccine infrastructure.<\/p>

<\/p>

Through the Network two vaccine manufacturing hubs have been established to streamline vaccine manufacturing. A £10 million award to Professor Robin Shuttock at Imperial College London aims to revolutionise the vaccine manufacture, stabilisation and storage, reducing costs, increasing efficiency and improving prevention of existing and new diseases. A £7 million award to Professor Tarit Mukhopadhyay at University College London aims to establish the UK as a global centre for vaccine discovery, development and manufacture, while also ensuring that new vaccine manufacturing processes can be used in low and middle income countries.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4372", "label" : {"_value" : "Biography information for Amanda Solloway"} } , "answeringMemberConstituency" : {"_value" : "Derby North"} , "answeringMemberPrinted" : {"_value" : "Amanda Solloway"} , "dateOfAnswer" : {"_value" : "2020-03-03", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-03-03T16:02:27.333Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2020-02-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccination: Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Department for Business Energy and Industrial Strategy, if he will make an assessment of the potential merits of directing UKRI to fund research into platform vaccine and diagnostic tools to support the development of vaccines during a potential pandemic.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "21237"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }